HPGC Renmintongtai Pharmaceutical CorporationSSE: 600829

Report for Q1 2025

Apr 19, 2025 · Issued by HPGC Renmintongtai Pharmaceutical Corporation via Shanghai Stock Exchange

Filed with SSE · Apr 19, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-135

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

HPGC Renmintongtai Pharmaceutical Corporation on 6ix

Earlier from HPGC Renmintongtai Pharmaceutical

Announcement on Resolution of the 18th Meeting of the 10th Board of DirectorsApr 12, 2025
Announcement on the Resignation and Appointment of General ManagerFeb 18, 2025
Announcement on Implementing the "Corporate Value and Return Enhancement" Action PlanDec 31, 2024
Announcement on Progress in Retrial of Significant Litigation MattersDec 17, 2024
Report for Q3 2024Oct 22, 2024

Later from HPGC Renmintongtai Pharmaceutical

Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend BriefingMay 7, 2025
Announcement on Outline of the 2024 Annual and Q1 2025 Performance and Cash Dividend BriefingMay 15, 2025
Announcement on Resolution of the 20th Meeting of the 10th Board of DirectorsJun 5, 2025
Announcement on Election of Employee DirectorJun 21, 2025
Announcement on Resolutions of the 1st Meeting of the 11th Board of DirectorsJun 27, 2025

All HPGC Renmintongtai Pharmaceutical news releases

Follow HPGC Renmintongtai Pharmaceutical into a list and get an email when it puts out news.

Follow HPGC Renmintongtai Pharmaceutical